🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a noninterventional, observational, long-term follow-up (LTFU) stud...
Status
Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2025-12-12
Trial ID
NCT06887348
Treatments Being Tested
The research study is being conducted to study whether performing injection...
Status
Not Yet Recruiting
Location
Abramson Cancer Center at the University of Pennsylvania
Start Date
2026-09-01
Trial ID
NCT07059611
InsightRP2 is a secure online patient registry specific to RP2-associated r...
Status
Recruiting
Location
University Medicine Göttingen
Start Date
2025-05-01
Trial ID
NCT06982417
Dose escalation phase 1 study of PARP inhibitor PF-01367338 in combination ...
Status
Completed
Location
Churchill Hospital
Start Date
2010-02
Trial ID
NCT01009190
Treatments Being Tested
This non-randomized, open-label, multicenter study will evaluate the safety...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2013-09-30
Trial ID
NCT01871805
Treatments Being Tested
Phase 1 study comprised of open-label, dose escalation, multiple cohorts of...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2022-05-05
Trial ID
NCT04960579
Treatments Being Tested
This study tests a new medication for treatment of kidney cancer, called BE...
Status
Terminated
Location
Memorial Sloan Kettering Cancer Center
Start Date
2011-10
Trial ID
NCT01453595
Treatments Being Tested
The purpose of this study is to treat participants with the combination of ...
Status
Terminated
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2019-08-30
Trial ID
NCT03818776
Treatments Being Tested
Prostate cancer is the most common cancer in American men. Surgical removal...
Status
Completed
Location
University of California, San Francisco
Start Date
2010-09
Trial ID
NCT01325506
Treatments Being Tested
This is a multicenter, open-label, Phase 1b/2 study which will be conducted...
Status
Terminated
Location
Dana-Farber Cancer Institute
Start Date
2011-10-13
Trial ID
NCT01433991
Treatments Being Tested